Atrial fibrillation monitoring to reduce thromboembolic risk: Selecting the patient and the monitoring device
Key result
Continuous ICM monitoring identifies silent AF in ~20% of cryptogenic stroke patients.
Why the study?
The silent and intermittent nature of atrial fibrillation complicates identification of patients at risk of thromboembolism, highlighting the importance of AF monitoring.
Population
Patients at risk of thromboembolism, particularly those with cryptogenic stroke
Comparison
Atrial fibrillation monitoring using implantable cardiac monitors versus no or less intensive monitoring
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Device-detected subclinical AF linked to thromboembolism; leaves open optimal anticoagulation thresholds in CIED patients.
Structured PICO
P
Population
Patients at risk of thromboembolism, particularly those with cryptogenic stroke
I
Intervention
Atrial fibrillation monitoring (e.g., continuous monitoring with implantable cardiac monitors)
Continuous monitoring with implantable cardiac monitors is useful in patients with cryptogenic stroke to identify silent atrial fibrillation and guide antithrombotic therapy.
Cite This Study
Barra et al. (2017) conducted a review in Atrial fibrillation. Atrial fibrillation monitoring was evaluated. Continuous monitoring with implantable cardiac monitors in patients with cryptogenic stroke identifies silent atrial fibrillation with a prevalence of approximately 20%.